Published in

Springer Nature [academic journals on nature.com], Blood Cancer Journal, 2(11), 2021

DOI: 10.1038/s41408-021-00424-4

Links

Tools

Export citation

Search in Google Scholar

Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes

Journal article published in 2021 by Konstantinos Liapis ORCID, Vasileios Papadopoulos ORCID, George Vrachiolias, Athanasios G. Galanopoulos, Menelaos Papoutselis, Sotirios G. Papageorgiou, Panagiotis T. Diamantopoulos, Vassiliki Pappa, Nora-Athina Viniou, Alexandra Kourakli, Dimitris Τsokanas, Theodoros P. Vassilakopoulos, Eleftheria Hatzimichael ORCID, Eleni Bouronikou, Maria Ximeri and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO